Myla D Goldman1, Robert W Motl, John Scagnelli, John H Pula, Jacob J Sosnoff, Diego Cadavid. 1. From the Department of Neurology (M.D.G.), University of Virginia, Charlottesville, VA; University of Illinois (R.W.M., J.J.S.), Urbana, IL; Raleigh Neurology Associates (J.S.), Raleigh, NC; University of Illinois College of Medicine at Peoria (J.H.P.), IL; and Biogen Idec (D.C.), Cambridge, MA.
Abstract
OBJECTIVE: Identify and validate clinically meaningful Timed 25-Foot Walk (T25FW) performance benchmarks in individuals living with multiple sclerosis (MS). METHODS: Cross-sectional study of 159 MS patients first identified candidate T25FW benchmarks. To characterize the clinical meaningfulness of T25FW benchmarks, we ascertained their relationships to real-life anchors, functional independence, and physiologic measurements of gait and disease progression. Candidate T25FW benchmarks were then prospectively validated in 95 subjects using 13 measures of ambulation and cognition, patient-reported outcomes, and optical coherence tomography. RESULTS: T25FW of 6 to 7.99 seconds was associated with a change in occupation due to MS, occupational disability, walking with a cane, and needing "some help" with instrumental activities of daily living; T25FW ≥8 seconds was associated with collecting Supplemental Security Income and government health care, walking with a walker, and inability to do instrumental activities of daily living. During prospective benchmark validation, we trichotomized data by T25FW benchmarks (<6 seconds, 6-7.99 seconds, and ≥8 seconds) and found group main effects on 12 of 13 objective and subjective measures (p < 0.05). CONCLUSIONS: Using a cross-sectional design, we identified 2 clinically meaningful T25FW benchmarks of ≥6 seconds (6-7.99) and ≥8 seconds. Longitudinal and larger studies are needed to confirm the clinical utility and relevance of these proposed T25FW benchmarks and to parse out whether there are additional benchmarks in the lower (<6 seconds) and higher (>10 seconds) ranges of performance.
OBJECTIVE: Identify and validate clinically meaningful Timed 25-Foot Walk (T25FW) performance benchmarks in individuals living with multiple sclerosis (MS). METHODS: Cross-sectional study of 159 MS patients first identified candidate T25FW benchmarks. To characterize the clinical meaningfulness of T25FW benchmarks, we ascertained their relationships to real-life anchors, functional independence, and physiologic measurements of gait and disease progression. Candidate T25FW benchmarks were then prospectively validated in 95 subjects using 13 measures of ambulation and cognition, patient-reported outcomes, and optical coherence tomography. RESULTS: T25FW of 6 to 7.99 seconds was associated with a change in occupation due to MS, occupational disability, walking with a cane, and needing "some help" with instrumental activities of daily living; T25FW ≥8 seconds was associated with collecting Supplemental Security Income and government health care, walking with a walker, and inability to do instrumental activities of daily living. During prospective benchmark validation, we trichotomized data by T25FW benchmarks (<6 seconds, 6-7.99 seconds, and ≥8 seconds) and found group main effects on 12 of 13 objective and subjective measures (p < 0.05). CONCLUSIONS: Using a cross-sectional design, we identified 2 clinically meaningful T25FW benchmarks of ≥6 seconds (6-7.99) and ≥8 seconds. Longitudinal and larger studies are needed to confirm the clinical utility and relevance of these proposed T25FW benchmarks and to parse out whether there are additional benchmarks in the lower (<6 seconds) and higher (>10 seconds) ranges of performance.
Authors: Libertje V A E Bosma; Jolijn J Kragt; Dirk L Knol; Chris H Polman; Bernard M J Uitdehaag Journal: Mult Scler Date: 2011-08-25 Impact factor: 6.312
Authors: A S Drake; B Weinstock-Guttman; S A Morrow; D Hojnacki; F E Munschauer; R H B Benedict Journal: Mult Scler Date: 2009-12-22 Impact factor: 6.312
Authors: Jacob J Sosnoff; Madeline Weikert; Deirdre Dlugonski; Douglas C Smith; Robert W Motl Journal: Gait Posture Date: 2011-04-30 Impact factor: 2.840
Authors: Douglas N Martini; Eline Zeeboer; Andrea Hildebrand; Brett W Fling; Cinda L Hugos; Michelle H Cameron Journal: Arch Phys Med Rehabil Date: 2018-06-26 Impact factor: 3.966
Authors: Bryan D Loy; Brett W Fling; Fay B Horak; Dennis N Bourdette; Rebecca I Spain Journal: Complement Ther Med Date: 2018-09-22 Impact factor: 2.446
Authors: Myla D Goldman; Melanie D Ward; Robert W Motl; David E Jones; John H Pula; Diego Cadavid Journal: Mult Scler Date: 2016-12-07 Impact factor: 6.312
Authors: Awad M Almuklass; Leah Davis; Landon D Hamilton; Taian M Vieira; Alberto Botter; Roger M Enoka Journal: J Neurophysiol Date: 2018-01-03 Impact factor: 2.714
Authors: Kathleen M Zackowski; Joseph I Wang; John McGready; Peter A Calabresi; Scott D Newsome Journal: Mult Scler Relat Disord Date: 2015-01 Impact factor: 4.339